behnamnabet Profile Banner
Behnam Nabet Profile
Behnam Nabet

@behnamnabet

Followers
1K
Following
3K
Statuses
1K

Assistant Professor @fredhutch | dTAG designer | Proud Husband & Baba | He/Him/His

Seattle, WA
Joined March 2018
Don't wanna be here? Send us removal request.
@behnamnabet
Behnam Nabet
2 months
Ready, set, degrade! So proud to share our work in @jclinicalinvest, establishing a versatile approach for creating transgenic dTAG mice to degrade oncoproteins. We showcase that KRAS G12V degradation triggers antitumor immunity in lung cancer. Link: 🧵
Tweet media one
7
23
124
@behnamnabet
Behnam Nabet
22 days
RT @jclinicalinvest: Targeting the most frequently mutated oncogene in lung adenocarcinoma promotes antitumor immunity. @HuaZhangLab @behn…
0
8
0
@behnamnabet
Behnam Nabet
27 days
@HsiehLab Thanks so much, Andrew!
0
0
1
@behnamnabet
Behnam Nabet
28 days
@science_seattle @fredhutch Thanks so much for highlighting our work team!
0
0
2
@behnamnabet
Behnam Nabet
28 days
RT @science_seattle: Dr. @BehnamNabet at @fredhutch and his team have found a new way to throw misbehaving, cancer-causing proteins in the…
0
3
0
@behnamnabet
Behnam Nabet
1 month
RT @fredhutch: In a study published today in @jclinicalinvest, @behnamnabet and collaborators describe how they used targeted protein degra…
0
8
0
@behnamnabet
Behnam Nabet
1 month
Many thanks to @jhigginsST @fredhutch for this fantastic article showcasing our latest dTAG study! I am so proud of our amazing team!!
@fredhutch
Fred Hutchinson Cancer Center
1 month
In a study published today in @jclinicalinvest, @behnamnabet and collaborators describe how they used targeted protein degradation in mice to rapidly destroy lung and pancreas tumors caused by a variant of a commonly mutated, cancer-driving gene.
0
2
8
@behnamnabet
Behnam Nabet
1 month
RT @oncodaily: Establishing a versatile approach for creating transgenic dTAG mice to degrade oncoproteins - @behnamnabet (@fredhutch) htt…
0
3
0
@behnamnabet
Behnam Nabet
2 months
RT @HsiehLab: Congrats @behnamnabet!
0
2
0
@behnamnabet
Behnam Nabet
2 months
@HsiehLab Thanks so much, Andrew!
0
0
0
@behnamnabet
Behnam Nabet
2 months
RT @aliceb_phd: Such a powerful system for studying RAS therapeutics and biology!
0
1
0
@behnamnabet
Behnam Nabet
2 months
@aliceb_phd Thanks so much for all your help and support on this effort! So excited for our collaborations :)
0
0
1
@behnamnabet
Behnam Nabet
2 months
@GhajarLab Thanks, Cyrus! :)
0
0
1
@behnamnabet
Behnam Nabet
2 months
RT @GhajarLab: Check out this new important work from Behnam Nabet and collaborators 👇🏼
0
3
0
@behnamnabet
Behnam Nabet
2 months
RT @LabSethi: Beautiful work! Figure 7 is insightful. TME changes in response to tumor regression can be bystander events. To show CD8+ T-c…
0
1
0
@behnamnabet
Behnam Nabet
2 months
@LabSethi Thank you!
0
0
0
@behnamnabet
Behnam Nabet
2 months
RT @Aiims1742: Link to the @jclinicalinvest paper below: The preprint from 10 days prior also generated FKBP12F36V-…
0
1
0
@behnamnabet
Behnam Nabet
2 months
RT @Aiims1742: A second KRASG12V degrader manuscript in ten days. This one is published in @jclinicalinvest and details preclinical studie…
0
16
0
@behnamnabet
Behnam Nabet
2 months
RT @Saurav054: Excited to share our amazing work demonstrating that the degradation of KRAS G12V by dTAG induces antitumor immunity in a tr…
0
1
0